Pegloticase for Severe Chronic Gout: When Standard Treatments Fail
Pegloticase (Krystexxa) is a specialized biologic medication for severe, treatment-resistant gout that rapidly lowers uric acid levels and can dissolve tophi when other treatments have failed.
How Pegloticase Works
Pegloticase is a recombinant, PEGylated uricase enzyme that converts uric acid into a more soluble compound called allantoin, which is easily eliminated by the kidneys.
Unlike humans, most mammals naturally produce uricase, which helps them maintain lower uric acid levels. Pegloticase essentially provides this missing enzyme, allowing for rapid and dramatic lowering of uric acid levels, even in patients with extensive crystal deposits or tophi.
Administration & Schedule
Pegloticase requires a different approach than oral gout medications:
Administration: Given as an intravenous infusion over about 2 hours
Frequency: Typically administered every 2 weeks
Setting: Infusions take place at a healthcare facility where patients can be monitored for reactions
Pre-medication: Often includes antihistamines and corticosteroids to reduce risk of infusion reactions
Monitoring: Uric acid levels are checked before each infusion to ensure continued effectiveness
Many rheumatologists now combine pegloticase with immunomodulatory drugs like methotrexate to reduce the development of antibodies against pegloticase, which can make it less effective over time.
Side Effects and Considerations
Pegloticase has significant potential side effects that require careful monitoring:
High risk of infusion reactions, especially if uric acid levels are elevated before infusion
Not appropriate for patients with G6PD deficiency
Development of antibodies can reduce effectiveness over time in some patients
Requires temporary discontinuation of other uric acid-lowering therapies
Important Warning:
Pegloticase can cause serious allergic reactions (anaphylaxis) during or after the infusion. This risk increases if you continue treatment after developing high uric acid levels. Always have your uric acid levels tested prior to each infusion.
Effectiveness for Severe Gout
For patients who can tolerate it, pegloticase can provide dramatic benefits for severe gout:
Can rapidly lower uric acid to undetectable levels in patients who respond to treatment
May completely dissolve visible tophi (urate crystal deposits) within 6-12 months in many patients
Can significantly improve quality of life for patients with debilitating, chronic gout
Most effective when continued over time and when combined with immunomodulatory therapy to prevent antibody formation
Is Pegloticase Right for Your Severe Gout?
Get a personalized Gout Clarity Plan with expert recommendations for advanced gout treatment options when conventional therapies have failed.
Pegloticase is a powerful IV drug that breaks down uric acid fast—like a cleanup crew for people with severe, stubborn gout that doesn't respond to pills.
It's usually for people with advanced gout, tophi, or joint damage who haven't improved with other meds. Think of it as the option when nothing else has worked.
It's given by infusion every two weeks in a clinic. This isn't a pill—you'll need to go in, sit down, and be monitored.
Fast. Most people see their levels drop within days. But it needs to be continued regularly to keep those levels down.
The big one is infusion reactions—sometimes serious. To reduce the risk, doctors often pair it with immune-suppressing drugs like methotrexate.
No—those meds can interfere with how pegloticase works. You'll likely need to stop them before starting treatment.
If your uric acid stays high or flares keep happening after a few infusions, your body might be making antibodies that block the drug.
It's expensive, requires infusions, and carries risks. But for people with uncontrolled gout, it can be life-changing.
Often yes—but prior authorization is almost always required. It's a specialty drug, so expect paperwork.
Not exactly. It can reverse damage and lower uric acid dramatically, but stopping the drug without a backup plan can lead to relapse.
Need Support for Advanced Gout Treatment?
Our Gout Clarity Plan provides resources and guidance for navigating complex treatment options like pegloticase, including help with insurance coverage.
Delivered within 24 hours. Personalized to you.
This website uses cookies to improve your experience and analyze site traffic.
By clicking "Accept", you consent to our use of cookies.